Understanding the Angiogenic Characteristics of Clinical-Grade Mesenchymal Stromal Cells Isolated from Human Umbilical Cord
-
Published:2024-03-16
Issue:5
Volume:20
Page:1353-1356
-
ISSN:2629-3269
-
Container-title:Stem Cell Reviews and Reports
-
language:en
-
Short-container-title:Stem Cell Rev and Rep
Author:
Carcopino Charlotte, Rossi Elisa, Mebarki Miryam, El Hamaoui Divina, Gaussem Pascale, Larghero Jérôme, Smadja David M.ORCID, Cras Audrey
Funder
AP-HP Université Paris Descartes Inserm
Publisher
Springer Science and Business Media LLC
Reference6 articles.
1. Blandinieres, A., Randi, A. M., Paschalaki, K. E., Guerin, C. L., Melero-Martin, J. M., & Smadja, D. M. (2023). Results of an international survey about methods used to isolate human endothelial colony-forming cells (ECFCs): Guidance from the Scientific and Standardization Committee on Vascular Biology of the International Society of Thrombosis and hemostasis. Journal of Thrombosis and Haemostasis, S1538–7836(23), 00498–00501. 2. Kehl, D., Generali, M., Mallone, A., Heller, M., Uldry, A. C., Cheng, P., et al. (2019). Proteomic analysis of human mesenchymal stromal cell secretomes: A systematic comparison of the angiogenic potential. NPJ Regenerative Medicine [Internet]. Apr 16 [cited 2021 May 27];4. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467904/ 3. Mebarki, M., Iglicki, N., Marigny, C., Abadie, C., Nicolet, C., Churlaud, G., et al. (2021). Development of a human umbilical cord-derived mesenchymal stromal cell-based advanced therapy medicinal product to treat immune and/or inflammatory diseases. Stem Cell Research & Therapy, 12(1), 571. 4. Monsel, A., Hauw-Berlemont, C., Mebarki, M., Heming, N., Mayaux, J., NguekapTchoumba, O., et al. (2022). Treatment of COVID-19-associated ARDS with mesenchymal stromal cells: A multicenter randomized double-blind trial. Critical Care, 26, 48. 5. Bronckaers, A., Hilkens, P., Martens, W., Gervois, P., Ratajczak, J., Struys, T., et al. (2014). Mesenchymal stem/stromal cells as a pharmacological and therapeutic approach to accelerate angiogenesis. Pharmacology & Therapeutics, 143(2), 181–196.
|
|